| Advice Pool |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Drug Abuse > Pain Killer Addictions |
|
Advice Pool - Pain Killer Addictions
The physical process that leads to pain killer addictions is as follows: 1. The brain responds to the presence of the pa According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product in killer by increasing the number of available receptors for the drug, so that the nerve cells in the brains stops functioning nor ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ally. 2. The body has natural pain killers called endorphins. Once pain killer medication is taken, the body reacts by ceas lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ng the production of endorphins to receive the opiates instead. 3. Degeneration of nerve cells in the brain leads to physi here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe al dependency on an outside supply of opiates, so hat reduction or stoppage of the intake of this drug may cause painful physical c d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro anges, more commonly known as withdrawal syndrome. When the patient approaches this point, he may continue to take the pain ki ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ler in order to avoid the changes associated to withdrawal symptoms, instead of taking it to treat the pain he originally felt. Lit easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi tle does he know that continually taking pain killer medication causes major changes in his brain chemistry that is not under his c nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ntrol. It is considered a disease, and it is a physical and chemical one, one that requires medical treatment delivered by an exper and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ in a humane and safe environment. It is very important to note that taking pain killer medication can in fact, only increase one' ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi sensitivity to pain, a condition called hyperalgesia. Many patients discover that once they are off their opiate medications, thei ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a pain is actually much less than they initially thought, or that there is completely no pain anymore. This happens because long ter dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod chronic use of pain killers caused their decrease in ability to tolerate pain, as well as an increased sensitivity to any form of cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin iscomfort. After long term use, even if the injury has long gone, the intensity of pain and discomfort is increased significantly, tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen so that patients tend to believe that they still need to continue taking the medication at much higher doses. Also, it can be har t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel to distinguish between general body aches from pains caused by withdrawal symptoms. The patient might take the pill and notice tha ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust it is effective, and that it works. But in reality, the pain killer medication is actually no longer needed for the initial proble y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products , but because he body already has become dependent on them. It is important to get off pain killer addiction immediately in order t . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de avoid getting more physiologically dependent and so that patients can return to their normal lives again. For more information on elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip pain killer addictions, their effects and how to handle this addiction problem, you can visit http://www.mypainkilleraddictions.com tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:20 Business Telephone Etiquette Tips Real Estate Sales - A Scary Business
|